1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29695239 | Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity. | 2018 Apr 25 | 1 |